During the past decade, Ahmanson-UCLA Cardiomyopathy Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ahmanson-UCLA Cardiomyopathy Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ahmanson-UCLA Cardiomyopathy Center" are "Heart Failure" (3 trials), "Diabetes" (2 trials), "Heart Failure, Congestive" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Ahmanson-UCLA Cardiomyopathy Center" in a lesser frequency.

Most popular intervention types in "Ahmanson-UCLA Cardiomyopathy Center" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Metformin" (2 trials), "Body Composition Analysis InBody Scale" (1 trials), "atorvastatin" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ahmanson-UCLA Cardiomyopathy Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ahmanson-UCLA Cardiomyopathy Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Ahmanson-UCLA Cardiomyopathy Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ahmanson-UCLA Cardiomyopathy Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".